- known history of ekg qtc prolongation abnormality - contraindication or allergy to hydroxychloroquine - retinal eye disease - known glucose-6 phosphate dehydrogenase (g-6-pd) deficiency - known chronic kidney disease, stage 4 or 5 or receiving dialysis - weight < 40 kg - current use of: hydroxychloroquine or cardiac medicines of: flecainide, tambocor; amiodarone, cordarone, pacerone; digoxin or digox, digitek, lanoxin; procainamide or procan, procanbid, propafenone, rythmal) - known hepatic disease (cirrhosis, hepatitis) - active treatment for cancer (chemotherapy, radiation, surgery within 3 months - on immunosuppressive drugs steroids, antirejection medications. - recipient of solid organ transplant - pregnancy/breastfeeding - past medical history porphyria (may exacerbate disease) - pmh psoariasis (can worsen disease) - no access to internet or email - current suicidal thoughts according to columbia scale - in the screening process before signing consent, subjects will be asked if they are suicidal. if this response is yes, patients will be excluded from trial and directed to the national suicide prevention lifeline: 1-800-273-8255.

- known history of ekg qtc prolongation abnormality - contraindication or allergy to hydroxychloroquine - retinal eye disease - known glucose-6 phosphate dehydrogenase (g-6-pd) deficiency - known chronic kidney disease, stage 4 or 5 or receiving dialysis - weight < 40 kg - current use of: hydroxychloroquine or cardiac medicines of: flecainide, tambocor; amiodarone, cordarone, pacerone; digoxin or digox, digitek, lanoxin; procainamide or procan, procanbid, propafenone, rythmal) - known hepatic disease (cirrhosis, hepatitis) - active treatment for cancer (chemotherapy, radiation, surgery within 3 months - on immunosuppressive drugs steroids, antirejection medications. - recipient of solid organ transplant - pregnancy/breastfeeding - past medical history porphyria (may exacerbate disease) - pmh psoariasis (can worsen disease) - no access to internet or email - current suicidal thoughts according to columbia scale - in the screening process before signing consent, subjects will be asked if they are suicidal. if this response is yes, patients will be excluded from trial and directed to the national suicide prevention lifeline: 1-800-273-8255.